Authors:
KLINGER W
LUPP A
KARGE E
OELSCHLAGER H
ROTHLEY D
DANZ M
LINSS W
LOBEL S
DEUFEL T
MULLER M
KLINGER M
KUHNEL W
Citation: W. Klinger et al., CIPROFIBRATE-RACEMATE AND ENANTIOMERS - EFFECTS OF A 4-WEEK TREATMENTON MALE INBRED FISCHER RATS - A BIOCHEMICAL AND MORPHOLOGICAL-STUDY, Experimental and toxicologic pathology, 50(4-6), 1998, pp. 301-314
Authors:
OELSCHLAGER H
ROTHLEY D
KLINGER W
KARGE E
VOGELSANG H
Citation: H. Oelschlager et al., CHROMATOGRAPHIC RESOLUTION OF CIPROFIBRATE AND INTERACTION OF THE RACEMATE AND BOTH ENANTIOMERS WITH RAT-LIVER MICROSOMES IN-VITRO, Experimental and toxicologic pathology, 50(4-6), 1998, pp. 323-329
Authors:
OELSCHLAGER H
KLINGER W
ROTHLEY D
SEELING A
BOCKHARD H
HOFMANN B
MACHTS H
RIEDERER H
RACKUR H
Citation: H. Oelschlager et al., CLEAVAGE ACID BIOTRANSFORMATION OF THE CENTRALLY ACTING MUSCLE-RELAXANT CHLORMEZANONE, Die Pharmazie, 53(9), 1998, pp. 620-624
Authors:
KLINGER W
OELSCHLAGER H
KARGE E
ROTHLEY D
Citation: W. Klinger et al., INTERACTION OF CHLORMEZANONE WITH RAT-LIVER MICROSOMES AND ITS DEGRADATION, European journal of drug metabolism and pharmacokinetics, 22(2), 1997, pp. 165-171
Citation: C. Kohl et al., IDENTIFICATION OF DRUG GLUCURONIDES IN HUMAN URINE BY RP-HPLC AFTER DERIVATIZATION, Journal of pharmaceutical and biomedical analysis, 12(2), 1994, pp. 249-254
Citation: H. Oelschlager et al., PHARMACOKINETICS OF HYPOLIPIDEMIC AGENTS, X(- 2ND CONTRIBUTION TO THEPROBLEM OF THE DEHALOGENATION OF THE LIPID-LOWERING AGENT CIPROFIBRATE() ), Archiv der pharmazie, 327(4), 1994, pp. 261-265